Yes. What could happen is that, for instance, it could be under special authority; that's what they do in Australia. Your physician makes the case that other treatments haven't been successful for you, so it might be a second- or third-line treatment. You could then apply to be part of this research program; you'd have to agree to be part of it.
If you're a Canadian with diabetes and you are not having the best health outcomes from your current treatment and your physician thinks this new drug might be useful, then you could enter the research program. That's what we were thinking.